{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T05:58:15Z","timestamp":1718171895705},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T00:00:00Z","timestamp":1544745600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00393-018-0573-8","type":"journal-article","created":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T09:15:10Z","timestamp":1544778910000},"page":"55-65","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Facettenreichtum des Morbus Whipple"],"prefix":"10.1007","volume":"78","author":[{"given":"M.","family":"Sluszniak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. H.","family":"Tarner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Schmeiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,14]]},"reference":[{"key":"573_CR1","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1128\/AAC.47.5.1658-1664.2003","volume":"47","author":"F Masselot","year":"2003","unstructured":"Masselot F, Boulos A, Maurin M et\u00a0al (2003) Molecular evaluation of antibiotic susceptibility: Tropheryma whipplei paradigm. Antimicrob Agents Chemother 47:1658\u20131664","journal-title":"Antimicrob Agents Chemother"},{"key":"573_CR2","first-page":"382","volume":"18","author":"GH Whipple","year":"1907","unstructured":"Whipple GH (1907) A hitherto undescribed disease characterized anatomically by deposits of fat and fatty acids in the intestinal and mesenteric lymphatic tissues. Bull Johns Hopkins Hosp 18:382","journal-title":"Bull Johns Hopkins Hosp"},{"key":"573_CR3","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.cmi.2016.07.005","volume":"22","author":"F Fenollar","year":"2016","unstructured":"Fenollar F, Minodier P, Boutin A et\u00a0al (2016) Tropheryma whipplei associated with diarrhoea in young children. Clin Microbiol Infect 22:869\u2013874","journal-title":"Clin Microbiol Infect"},{"key":"573_CR4","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1016\/j.ijid.2012.05.1033","volume":"17","author":"AK Keita","year":"2013","unstructured":"Keita AK, Brouqui P, Badiaga S et\u00a0al (2013) Tropheryma whipplei prevalence strongly suggests human transmission in homeless shelters. Int J Infect Dis 17:e67\u2013e68","journal-title":"Int. J. Infect. Dis."},{"key":"573_CR5","volume-title":"Whipple\u2019s disease","author":"WO Dobbins III","year":"1987","unstructured":"Dobbins WO III (1987) Whipple\u2019s disease. Charles C Thomas, Springfield"},{"key":"573_CR6","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/MD.0b013e3181f204a8","volume":"89","author":"JC Lagier","year":"2010","unstructured":"Lagier JC, Lepidi H, Raoult D, Fenollar F (2010) Systemic Tropheryma whipplei: clinical presentation of 142 patients with infections diagnosed or confirmed in a\u00a0reference center. Medicine 89:337\u2013345","journal-title":"Medicine"},{"key":"573_CR7","first-page":"442","volume":"113","author":"T Marth","year":"1997","unstructured":"Marth T, Neurath M, Cuccherini BA, Strober W (1997) Defects of monocyte interleukin 12 production and humoral immunity in Whipple\u2019s disease. Baillieres Clin Gastroenterol 113:442\u2013448","journal-title":"Baillieres Clin Gastroenterol"},{"key":"573_CR8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1006\/clin.1994.1134","volume":"72","author":"T Marth","year":"1994","unstructured":"Marth T, Roux M, von Herbay A et al (1994) Persistent reduction of complement receptor 3 alpha-chain expressing mononuclear blood cells and transient inhibitory serum factors in Whipple\u2019s disease. Clin Immunol Immunopathol 72:217\u2013226","journal-title":"Clin Immunol Immunopathol"},{"key":"573_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2559.1992.tb00337.x","volume":"21","author":"N Ectors","year":"1992","unstructured":"Ectors N, Geboes K, De Vos R et\u00a0al (1992) Whipple\u2019s disease: a\u00a0histological, immunocytochemical and electronmicroscopic study of the immune response in the small intestinal mucosa. Histopathology 21:1","journal-title":"Histopathology"},{"key":"573_CR10","doi-asserted-by":"publisher","first-page":"e13561","DOI":"10.1371\/journal.pone.0013561","volume":"5","author":"E Ghigo","year":"2010","unstructured":"Ghigo E, Barry AO, Pretat L et al (2010) IL-16 promotes T. whipplei replication by inhibiting phagosome conversion and modulating macrophage activation. PLoS ONE 5:e13561","journal-title":"PLoS ONE"},{"key":"573_CR11","first-page":"1468","volume":"123","author":"T Marth","year":"2002","unstructured":"Marth T, Kleen N, Stallmach A et\u00a0al (2002) Dysregulated peripheral and mucosal Th1\/Th2 response in Whipple\u2019s disease. Baillieres Clin Gastroenterol 123:1468\u20131477","journal-title":"Baillieres Clin Gastroenterol"},{"key":"573_CR12","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1128\/IAI.02463-14","volume":"83","author":"K Schinnerling","year":"2015","unstructured":"Schinnerling K, Geelhaar-Karsch A, Allers K et al (2015) Role of dendritic cells in the pathogenesis of Whipple\u2019s disease. Infect Immun 83:482\u2013491","journal-title":"Infect Immun"},{"key":"573_CR13","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1159\/000369538","volume":"33","author":"T Marth","year":"2015","unstructured":"Marth T (2015) Tropheryma whipplei, immunosuppression and Whipple\u2019s disease: from a\u00a0low-pathogenic, environmental infectious organism to a\u00a0rare, multifaceted inflammatory complex. Dig Dis 33:190\u2013199","journal-title":"Dig Dis"},{"key":"573_CR14","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/apt.13140","volume":"41","author":"T Marth","year":"2015","unstructured":"Marth T (2015) Systematic review: Whipple\u2019s disease and its unmasking by tumor necrosis factor inhibitors. Aliment Pharmacol Ther 41:709\u2013724","journal-title":"Aliment Pharmacol Ther"},{"key":"573_CR15","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1055\/s-0034-1398501","volume":"54","author":"T Marth","year":"2015","unstructured":"Marth T (2015) Klinische Verlaufsformen der Tropheryma whipplei Infektion und des Morbus Whipple \u2013 Bedeutung f\u00fcr die Rheumatologie. Akt Rheumatol 54:209\u2013218","journal-title":"Akt Rheumatol"},{"key":"573_CR16","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/00005792-199705000-00003","volume":"76","author":"DV Durand","year":"1997","unstructured":"Durand DV, Lecomte C, Cath\u00e9bras P et\u00a0al (1997) Whipple disease. Clinical review of 52 cases. The SNFMI Research Group on Whipple Disease. Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne. Medicine 76:170\u2013184","journal-title":"Medicine"},{"key":"573_CR17","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.jbspin.2016.07.001","volume":"83","author":"X Pu\u00e9chal","year":"2016","unstructured":"Pu\u00e9chal X (2016) Whipple\u2019s arthritis. Joint Bone Spine 83:631\u2013635","journal-title":"Joint Bone Spine"},{"key":"573_CR18","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/00002281-200101000-00012","volume":"13","author":"X Pu\u00e9chal","year":"2001","unstructured":"Pu\u00e9chal X (2001) Whipple\u2019s disease and arthritis. Curr Opin Rheumatol 13:74\u201379","journal-title":"Curr Opin Rheumatol"},{"key":"573_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1055\/s-0028-1123969","volume":"134","author":"K Ahmadi-Simab","year":"2009","unstructured":"Ahmadi-Simab K, Schnitzler P (2009) Morbus Whipple mit normaler D\u00fcnndarmhistologie bei ankylosierender Spondylitis. Dtsch Med Wochenschr 134:127\u2013130","journal-title":"Dtsch Med Wochenschr"},{"key":"573_CR20","first-page":"51","volume":"27","author":"D Blaison","year":"1991","unstructured":"Blaison D, Carteret E, Renard P et al (1991) A case of Whipple\u2019s disease with ankylosing spondylarthritis treated with trimethoprim-sulfamethoxazole. Ann Gastroenterol Hepatol (Paris) 27:51\u201355","journal-title":"Ann. Gastroenterol. Hepatol. (Paris)"},{"key":"573_CR21","first-page":"1294","volume":"28","author":"I Olivieri","year":"2001","unstructured":"Olivieri I, Brandi G, Padula A et al (2001) Lack of association with spondyloarthritis and HLA-B27 in Italian patients with Whipple\u2019s disease. J\u00a0Rheumatol 28:1294\u20131297","journal-title":"J Rheumatol"},{"key":"573_CR22","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jinf.2012.12.004","volume":"66","author":"GE Feurle","year":"2013","unstructured":"Feurle GE, Moos V, Bl\u00e4ker H et al (2013) Intravenous ceftriaxone, followed by 12 or three months of oral treatment with trimethoprim-sulfamethoxazole in Whipple\u2019s disease. J\u00a0Infect 66:263\u2013270","journal-title":"J Infect"},{"key":"573_CR23","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/MD.0000000000000010","volume":"92","author":"C Compain","year":"2013","unstructured":"Compain C, Sacre K, Pu\u00e9chal X et al (2013) Central nervous system involvement in Whipple disease: clinical study of 18 patients and longterm follow-up. Medicine 92:324\u2013330","journal-title":"Medicine"},{"key":"573_CR24","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1128\/JCM.05531-11","volume":"50","author":"W Geissd\u00f6rfer","year":"2012","unstructured":"Geissd\u00f6rfer W, Moos V, Moter A et al (2012) High frequency of Tropheryma whipplei in culture-negative endocarditis. J\u00a0Clin Microbiol 50:216\u2013222","journal-title":"J Clin Microbiol"},{"key":"573_CR25","doi-asserted-by":"publisher","first-page":"e4058","DOI":"10.1097\/MD.0000000000004058","volume":"95","author":"L Garc\u00eda-\u00c1lvarez","year":"2016","unstructured":"Garc\u00eda-\u00c1lvarez L, Sanz MM, Mar\u00edn M et al (2016) Tropheryma whipplei endocarditis in Spain: case reports of 17 prospective cases. Medicine 95:e4058","journal-title":"Medicine"},{"key":"573_CR26","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1600-0463.2004.apm1120309.x","volume":"112","author":"S Gunia","year":"2004","unstructured":"Gunia S, Behrennd MH, Stosiek P (2004) A rare course of Whipple\u2019s disease with atypical cardiac manifestation. APMIS 112:222\u2013224","journal-title":"APMIS"},{"key":"573_CR27","doi-asserted-by":"publisher","first-page":"e714","DOI":"10.1097\/MD.0000000000000714","volume":"94","author":"U G\u00fcnther","year":"2015","unstructured":"G\u00fcnther U, Moos V, Offenm\u00fcller G et\u00a0al (2015) Gastrointestinal diagnosis of classical Whipple disease: clinical, endoscopic, and histopathologic features in 191 patients. Medicine 94:e714","journal-title":"Medicine"},{"key":"573_CR28","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1056\/NEJM199207303270501","volume":"327","author":"DA Relman","year":"1992","unstructured":"Relman DA, Schmidt TM, MacDermott RP, Falkow S (1992) Identification of the uncultured bacillus of Whipple\u2019s disease. N\u00a0Engl J Med 327:293\u2013301","journal-title":"N Engl J Med"},{"key":"573_CR29","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1086\/514089","volume":"176","author":"G Schoedon","year":"1997","unstructured":"Schoedon G, Goldenberger D, Forrer R et al (1997) Deactivation of macrophages with interleukin-4 is the key to the isolation of Tropheryma whippelii. J\u00a0Infect Dis 176:672\u2013677","journal-title":"J Infect Dis"},{"key":"573_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy664","author":"A Moter","year":"2018","unstructured":"Moter A et\u00a0al (2018) Potential role for urine polymerase chain reaction in the diagnosis of Whipple\u2019s disease. Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/ciy664","journal-title":"Clin Infect Dis"},{"key":"573_CR31","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1055\/s-0034-1399337","volume":"53","author":"S Hagel","year":"2015","unstructured":"Hagel S, Epple HJ, Feurle GE (2015) S2k-Leitlinie Gastrointestinale Infektionen und Morbus Whipple. Z\u00a0Gastroenterol 53:418\u2013459","journal-title":"Z Gastroenterol"},{"key":"573_CR32","first-page":"478","volume":"138","author":"GE Feurle","year":"2010","unstructured":"Feurle GE, Junga NS, Marth T (2010) Efficacy of ceftriaxone or meropenem as initial therapies in Whipple\u2019s disease. Baillieres Clin Gastroenterol 138:478\u2013486","journal-title":"Baillieres Clin Gastroenterol"},{"key":"573_CR33","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1093\/jac\/dkr032","volume":"66","author":"JC Lagier","year":"2011","unstructured":"Lagier JC, Fenollar F, Lepidi H et\u00a0al (2011) Evidence of lifetime susceptibility to Tropheryma whipplei in patients with Whipple\u2019s disease. J\u00a0Antimicrob Chemother 66:1188\u20131189","journal-title":"J Antimicrob Chemother"},{"key":"573_CR34","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1093\/jac\/dkt310","volume":"69","author":"JC Lagier","year":"2014","unstructured":"Lagier JC, Fenollar F, Lepidi H et\u00a0al (2014) Treatment of classic Whipple\u2019s disease: from in vitro results to clinical outcome. J\u00a0Antimicrob Chemother 69:219\u2013227","journal-title":"J Antimicrob Chemother"},{"key":"573_CR35","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1111\/j.1365-2133.1996.tb03868.x","volume":"135","author":"GP Balestrieri","year":"1996","unstructured":"Balestrieri GP, Villanacci V, Battocchio S et\u00a0al (1996) Cutaneous involvement in Whipple\u2019s disease. Br J Dermatol 135:666\u2013668","journal-title":"Br J Dermatol"},{"key":"573_CR36","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/DAD.0000000000000008","volume":"36","author":"L Canal","year":"2014","unstructured":"Canal L, Fuente Dde L, Rodriguez-Moreno J et al (2014) Specific cutaneous involvement in Whipple disease. Am J Dermatopathol 36:344\u2013346","journal-title":"Am J Dermatopathol"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-018-0573-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-018-0573-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-018-0573-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T18:52:29Z","timestamp":1605639149000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-018-0573-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,14]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["573"],"URL":"https:\/\/doi.org\/10.1007\/s00393-018-0573-8","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,14]]},"assertion":[{"value":"14 December 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0Sluszniak, I.H.\u00a0Tarner, A.\u00a0Thiele und T.\u00a0Schmeiser geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}